Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TT-173 in Knee Arthroplasty
NCT02687399Phase 3Unknown
- Sponsor
- Thrombotargets Europe
- Start
- Jan 2016
- Primary completion
- Sep 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of TT-173, sponsored by Thrombotargets Europe. Status: unknown.
02
Drugs
TT-173
Beyond the preview
Go deeper on NCT02687399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02687399.